Editor | Curator

Advertisment

Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic Company.

Conference Call Today at 12:00 EST. As the TSX chart above show, investors appear to be warming up the the idea. Not many investors...

Mindcure (MCURF) and Awakn Life Sciences (AWKNF) Seek to Distribute Ketamine Protocol for Alcohol Use Disorder.

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform

Ft. Lauderdale Boat Show

Ft. Lauderdale Boat ShowOctober 27 - 31, 2021 Pila Pexton Yacht Charter SpecialistMerle Wood & Associates, Inc.Direct +1 401.862.1977   Office +1 401.619.4111  pilapexton@merlewood.com

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr. Sharmin Ghaznavi. Recent Wall Street...

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most. The Psychedelic Renaissance is roaring. Over the past...

2021 Psychedelic Investor Guide Released.

Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the most comprehensive and easy to use guide covering...

Psychedelic Investor TV

To appear on an upcoming episode on Psychedelic Investor TV in conjunction with New to the Street TV airing on News Max, contact Roland Rick Perry at 310-594-8062 or Roland@InstitutionalAnalyst.com...

2021 Psychedelic Investor Guide – October

OPEN GUIDE Updated Monthly.. Did we miss your publicly traded company? Contact Roland Perry 310-594-8062

Editor | Curator

Advertisment